Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report

BACKGROUND: Gemcitabine is currently the standard chemotherapy for the adjuvant treatment of pancreatic cancer. This chemotherapeutic agent is generally well-tolerated, myelosuppression and gastrointestinal toxicity being common side effects. Nevertheless, gemcitabine-induced pulmonary toxicity has...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenocchio, Elisabetta, Depetris, Ilaria, Campanella, Delia, Garetto, Lucia, Schianca, Fabrizio Carnevale, Galizia, Danilo, Grignani, Giovanni, Aglietta, Massimo, Leone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059971/
https://www.ncbi.nlm.nih.gov/pubmed/27733144
http://dx.doi.org/10.1186/s12885-016-2833-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059971/
https://www.ncbi.nlm.nih.gov/pubmed/27733144
http://dx.doi.org/10.1186/s12885-016-2833-9

Ejemplares similares